This may be related to the absence of the target antigen from the tumor cell surface that has been observed in response to single scFV-CAR T-cell therapy [12]; Previous data showed CD19 expression on plasma cells with characterized cancer stem cell- like properties is a poor prognostic indicator [24]. Here, CD19 is linked to cancer.